Nanoparticle Phoresis is a device similar to a wrist watch that can automatically modify or destroy one or more targets in the blood that have an adverse health effect, by the use of Nanoparticles in our body. The patent application for this Nanoparticle phoresis has been filed by Google with the World Intellectual Property Organization (WIPO). The targets include enzymes, proteins, hormones and harmful cells like cancer cells and thus this device is theoretically effective in detecting and curing cancer. Google claims that the device can also target the select proteins that are regarded as a partial cause of Parkinson's disease and thereby, the device can also be used to slow down the development of Parkinson's disease.
Nanoparticle Phoresis is a device similar to a wrist watch that can automatically modify or destroy one or more targets in the blood that have an adverse health effect, by the use of Nanoparticles in our body. The patent application for this Nanoparticle phoresis has been filed by Google with the World Intellectual Property Organization (WIPO). The targets include enzymes, proteins, hormones and harmful cells like cancer cells and thus this device is theoretically effective in detecting and curing cancer. Google claims that the device can also target the select proteins that are regarded as a partial cause of Parkinson's disease and thereby, the device can also be used to slow down the development of Parkinson's disease.
These functionalized nanoparticles in the blood selectively bind to those target cells and modify or destroy the target cells by the energy that is generated from the wearable device outside the body. The energy is directed to the wearer's subsurface vasculature and is beamed into the nanoparticles in the blood vessels which stimulate the harmful cells. Furthermore, the patent describes one or more functionalized nanoparticles to be magnetic and thus a magnetic field is generated by the wearable device. This magnetic field is said to concentrate on the bound targets in a lumen of the subsurface vasculature proximate to the wearable device. That is, the magnetic field tows the nanoparticles bound to the target cells towards the wearable device where it can be detected, counted and modified. This entire procedure ensures the adverse health effects caused by harmful cells to be reduced or eliminated.
The direction of the energy generated by the wearable device is also used on synthetic nanoparticles in a similar manner. This device, when commercially available has the tendency to reduce and even eliminate diseases like cancer and Parkinson's disease and is thus considered to be a boon by many. However, generating and releasing directed energy into the body has a heavy potential of being mishandled and misused. If they are indeed misused or the diseases are over-diagnosed, the repercussions of it would turn out to be disastrous. In the words of Professor Paul Workman, chief executive of the Institute of Cancer Research in London, the technology needs "very careful and rigorous analysis" before making it commercially available.
